About Tern Therapeutics
Tern Therapeutics is a private company based in Washington, District of Columbia, incorporated in 2023 in Delaware. It has reported $10,706,331 raised in two offerings on Form D since September 2024. Its chief executive is Alexander Bailey.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sep 25, 2026 | $3,727,518fully sold | 7 | $532K | EquityRule 506(c) | Form D ↗ |
| Aug 21, 2024 | Sep 6, 2024 | $6,978,813of $13.9M target | 4 | $1.7M | EquityRule 506(c) | Form D ↗ |
| Total, two offerings | $10,706,331 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Tern Therapeutics's Form D filed Sep 25, 2026.
MR
Matthew Rosini
Chief Financial and Administration Officer
On every Form D that Tern Therapeutics has filed: 2 filings, from Sep 6, 2024 to Sep 25, 2026.
AB
Alexander Bailey
Chief Executive Officer and director
On every Form D that Tern Therapeutics has filed: 2 filings, from Sep 6, 2024 to Sep 25, 2026.
KP
Kerry Propper
Director
On every Form D that Tern Therapeutics has filed: 2 filings, from Sep 6, 2024 to Sep 25, 2026.
SO
Steven Oliveira
Director
On every Form D that Tern Therapeutics has filed: 2 filings, from Sep 6, 2024 to Sep 25, 2026.
CO
Christina Ohnsman
Chief Medical Officer
On every Form D that Tern Therapeutics has filed: 2 filings, from Sep 6, 2024 to Sep 25, 2026.
